mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.1 |